Quick Answer
Q32 Bio Inc. reported Research And Development Expense of $19.16 million for the year ending 2025.
- Q32 Bio Inc. showed a decrease of -60.2% in Research And Development Expense from 2024 to 2025.
- This data is from Q32 Bio Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), Q32 Bio Inc.'s Research And Development Expense has declined by 10.4%.
- Historical annual values: Fiscal year 2025: $19.16 million | Fiscal year 2024: $48.14 million | Fiscal year 2023: $31.73 million | Fiscal year 2022: $98.35 million | Fiscal year 2021: $93.09 million | Fiscal year 2020: $100.39 million | Fiscal year 2019: $89.40 million | Fiscal year 2018: $47.95 million | Fiscal year 2017: $21.38 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: